Healthy Extracts (HYEX) Change in Account Payables (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Change in Account Payables came in at -$44600.0 in Q4 2025, down 567.31% year-on-year from $9544.0 in Q4 2024, and down 790.19% quarter-over-quarter from $6462.0 in Q3 2025.
Healthy Extracts (HYEX) Change in Account Payables (2015 - 2025) Analysis & Trends
Healthy Extracts' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$44600.0 for Q4 2025.
- On a quarterly basis, Change in Account Payables fell 567.31% year-over-year to -$44600.0 in Q4 2025; TTM through Dec 2025 was $24503.0, a 137.93% increase from a year earlier, with the FY2025 full-year figure at $24503.0, up 137.93% from the prior year.
- Change in Account Payables slipped to -$44600.0 in Q4 2025 per HYEX's latest filing, from $6462.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $76799.0 in Q3 2022 and bottomed at -$63495.0 in Q2 2024.
- The 5-year median for Change in Account Payables is $6462.0 (2025), against an average of $700.76.
- Across the five-year window, Change in Account Payables plunged 2840.94% in 2024 and jumped 4160.33% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $14109.0 in 2021, then sank by 261.25% to -$22751.0 in 2022, then soared by 312.32% to $48304.0 in 2023, then slumped by 80.24% to $9544.0 in 2024, then plunged by 567.31% to -$44600.0 in 2025.
- Per Business Quant, the three latest HYEX Change in Account Payables figures stand at -$44600.0 (Q4 2025), $6462.0 (Q3 2025), and $33969.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | -44,600.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -44,600.00 |
| Dec 31, 2025 | -44,600.00 |
| Sep 30, 2025 | 6,462.00 |
| Sep 30, 2025 | 6,462.00 |
| Jun 30, 2025 | 33,969.00 |
| Jun 30, 2025 | 33,969.00 |
| Mar 31, 2025 | 28,672.00 |
| Mar 31, 2025 | 28,672.00 |
| Dec 31, 2024 | 9,544.00 |
| Dec 31, 2024 | 9,544.00 |
| Sep 30, 2024 | -11,317.00 |
| Sep 30, 2024 | -11,317.00 |
| Jun 30, 2024 | -63,495.00 |
| Jun 30, 2024 | -63,495.00 |
| Mar 31, 2024 | 673.00 |
| Mar 31, 2024 | 673.00 |
| Dec 31, 2023 | 48,304.00 |
| Dec 31, 2023 | 48,304.00 |
| Sep 30, 2023 | -43,789.00 |
| Sep 30, 2023 | -43,789.00 |